...
首页> 外文期刊>Haemophilia: the official journal of the World Federation of Hemophilia >An exploratory comparison of single intra‐articular injection of platelet‐rich plasma vs hyaluronic acid in treatment of haemophilic arthropathy of the knee
【24h】

An exploratory comparison of single intra‐articular injection of platelet‐rich plasma vs hyaluronic acid in treatment of haemophilic arthropathy of the knee

机译:单血小板富含血小板血浆VS透明质酸的探索性比较治疗膝关节中血友病关节病

获取原文
获取原文并翻译 | 示例

摘要

Introduction Intra‐articular platelet‐rich plasma (PRP) injection therapy has been extensively applied in clinical practice to treat musculoskeletal disorders such as osteoarthritis, but the treatment for haemophilic arthropathy is rarely reported. Aims This study aimed to compare the efficacy of intra‐articular PRP vs hyaluronic acid (HA) injections in treating haemophilic arthropathy of knee joints. Patients Twenty‐two haemophilia patients (mean age, 41.1?±?1.7 [range, 20‐50]?years) with painful haemophilic arthropathy of the knee were enrolled for this open‐label and observer‐blind study. Methods Eleven patients were treated with a single intra‐articular injection of PRP and the other 11 received five consecutively weekly intra‐articular injections of HA. Outcome assessment included pain by visual analogue scale (VAS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Chinese Version and synovial change determined by ultrasonography. Results Platelet‐rich plasma and HA intra‐articular injection showed statistically significant reduction in VAS, WOMAC total score and hyperaemia score from baseline to 6‐month post‐treatment. Inter‐group comparison showed statistically significant difference in the change in VAS score, WOMAC pain score, physical function score and total score at 6?months, wherein PRP group showed sustained beneficial effect than HA group at 6?months. Conclusion Our study demonstrates that, in comparison with five weekly injections of HA, a single PRP injection resulted in better improvement in pain relief and knee joint function, and greater reduction in synovial hyperaemia for up to 6?months. Our results suggest that PRP may be practical and effective for haemophilic knee arthropathy, and further investigation is warranted.
机译:引入关节内富含血小板的血浆(PRP)注射治疗已广泛应用于临床实践,以治疗肌腱障碍等肌肉骨骼疾病,但很少报道血友病疗法的治疗。目的这项研究旨在比较关节内PRP与透明质酸(HA)注射治疗膝关节的嗜血歧视节肢动物的疗效。患者22名血友病患者(平均年龄,41.1〜±1.7 [范围,20-50]?岁月)膝关节疼痛的血友关节病评价这一开放标签和观察者盲目的研究。方法采用11例患者治疗11例患者,另外11例,另外11个连续每周收集HA内注射。结果评估包括视觉模拟量表(VAS),西部安大略省和麦克马斯特大学骨关节炎指数(WOWAC)中文版和滑膜变化通过超声检查确定。结果富含血小板的血浆和HA内关节内注射率显示出VAS,WOMAC总分和高血症成绩从基线到6个月后疗效减少。群体间比较显示VAS评分的变化,Womac疼痛评分,物理功能评分和6个月总分比统计学意义差异,其中PrP组在6个月内显示比HA组的持续有益效果。结论我们的研究表明,与五次HA的每周注射相比,单一的PRP注射导致疼痛缓解和膝关节功能的更好提高,加强高达6月的滑膜高血肿更低。我们的研究结果表明,PRP可能是实用的,对血友膝关节大学有效,并有权进一步调查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号